Agreed. And you won't see the offers that are not accepted by Dr J and team. I would not be surprised at all if we have already received unacceptable low-ball offers. To get the high-ball offers, though, it will take one thing, data. That way, as Emmitt says, the offer-makers can win the shareholders of their company.
Data will convince not only the shareholders but also the regulatory gate that all companies in Pharma must get through.
We'll get that data, and then the high-ball offers will come.
Keep on keeping on and staying long for the long haul
KOKO&SLLH